Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission

Maconi, Giovanni; Gridavilla, Daniele; Viganò, Caterina; Sciurti, Roberta; Asthana, Anil Kumar; Furfaro, Federica; Re, Federica; Ardizzone, Sandro; Ba, G.

doi:10.1007/s00384-014-1935-6

Cited by 35 publications

(35 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study confirmed that psychiatric comorbidity is a frequent condition in CD patients even in those in clinical remission, confirming previous data [ 5 ] and that depressed CD patients have altered coping strategies.…”

Section: Discussionsupporting

confidence: 92%

Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn’s Disease Patients in Clinical Remission

Viganò

Calzolari

Marinaccio

et al. 2016

Gastroenterology Research and Practice

Self Cite

View full text Add to dashboard Cite

Background and Aims. This study investigated the proportion of CD patients in clinical remission with clinical depression, and coping strategies in those with severe depressive disorders. Materials and Methods. One hundred consecutive CD patients in clinical remission were screened for anxiety and depression by using Hospital Anxiety and Depression Scale and patients with depressive symptoms were further investigated by means of Cognitive Behavioural Assessment 2.0 and Beck Depression Inventory (BDI). Afterwards the coping strategies were assessed through the Brief-COPE questionnaire. Results. Twenty-one patients had anxious symptoms and 16 had depressive symptoms with or without anxiety. Seven of these patients (43.8%) showed significant depressive symptoms. Compared to patients without psychiatric disorders, these patients showed significant lower score in “positive reframing” (p: 0.017) and in “planning” (p: 0.046) and higher score in “use of instrumental social support” (p < 0.001), in “denial” scale (p: 0.001), and in “use of emotional social support” (p: 0.003). Conclusions. Depressed CD patients in clinical remission may have dysfunctional coping strategies, meaning that they may not be able to implement functional strategies to manage at best stress related with their disease.

show abstract

Section: Discussionsupporting

confidence: 92%

Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn’s Disease Patients in Clinical Remission

Viganò

Calzolari

Marinaccio

et al. 2016

Gastroenterology Research and Practice

Self Cite

View full text Add to dashboard Cite

show abstract

“…The pCD patients had higher levels of anxiety, stress and depression, in accordance with the literature [12,13,34,35]. Stress and depression may be associated with immunological changes (infiltration of T and B cells, impaired healing, altered levels of defensins) as well as microbiological and genetic factors, all described in the genesis of perianal fistulas [36-38].…”

Section: Discussionsupporting

confidence: 83%

Psychometry and Pescatori projective test in coloproctological patients

Caetano

Oliveira

Gomes³

et al. 2017

aog

View full text Add to dashboard Cite

BackgroundPsychological assessment is not commonly performed nor easily accepted by coloproctological patients. Our aim was to evaluate the psychological component of coloproctological disorders using uncommon tools.MethodsThe 21-Item Depression Anxiety and Stress Scale and the Pescatori projective test were applied to coloproctological outpatients of the Gastroenterology Department of our hospital as well as to healthy volunteers.ResultsSeventy patients (median age 47 years, 22 male) divided in 4 groups (functional constipation, constipated irritable bowel syndrome, benign anorectal disease and perianal Crohn’s disease) and 52 healthy volunteers (age 45 years, 18 male) completed the tests. Proctological patients showed higher scores of depression (P<0.001), anxiety (P<0.001), and stress (P<0.001) compared to healthy participants. Compared to the control group, patients with functional constipation, irritable bowel syndrome and perianal Crohn’s disease maintained the highest scores in all subscales (P<0.05), while patients with benign anorectal disease only had higher anxiety and stress (P<0.001) scores. The patients’ also showed lower scores in the Pescatori projective test (P=0.012). A weak association between the projective test and the depression subscale was found (P=0.05).ConclusionProctological patients had higher scores of depression, anxiety and stress and lower scores in the Pescatori projective test compared to healthy controls.

show abstract

“…However, gender does appear to be linked to differences in psychosocial manifestations of the Psychological illness and inflammatory bowel disease disease. The majority of studies indicate that female gender is a predictor of anxiety and depression in IBD (32,72,76). Females are also believed to be more susceptible to the impact of IBD on HRQOL (77) potentially due to increased symptom perception in women (78).…”

Section: Factors Influencing Anxiety and Depression In Ibdmentioning

confidence: 99%

Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease

Abautret-Daly

Dempsey

Parra‐Blanco

et al. 2017

Acta Neuropsychiatr.

139

107

View full text Add to dashboard Cite

show abstract

Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission

Abstract: Anxiety is a frequent, often untreated, condition in patient affected by Crohn's disease in clinical remission. Female sex, history of perianal disease and perianal surgery are major risk factors for anxiety.

Cited by 35 publications

References 34 publications

Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn’s Disease Patients in Clinical Remission

Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn’s Disease Patients in Clinical Remission

Psychometry and Pescatori projective test in coloproctological patients

Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease

Contact Info

Product

Resources

About